Your browser doesn't support javascript.
loading
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.
Pérez-Then, Eddy; Lucas, Carolina; Monteiro, Valter Silva; Miric, Marija; Brache, Vivian; Cochon, Leila; Vogels, Chantal B F; Malik, Amyn A; De la Cruz, Elena; Jorge, Aidelis; De Los Santos, Margarita; Leon, Patricia; Breban, Mallery I; Billig, Kendall; Yildirim, Inci; Pearson, Claire; Downing, Randy; Gagnon, Emily; Muyombwe, Anthony; Razeq, Jafar; Campbell, Melissa; Ko, Albert I; Omer, Saad B; Grubaugh, Nathan D; Vermund, Sten H; Iwasaki, Akiko.
Afiliação
  • Pérez-Then E; Ministry of Health, Santo Domingo, Dominican Republic.
  • Lucas C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. carolina.lucas@yale.edu.
  • Monteiro VS; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Miric M; Two Oceans in Health, Santo Domingo, Dominican Republic.
  • Brache V; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic.
  • Cochon L; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic.
  • Vogels CBF; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Malik AA; Yale Institute for Global Health, Yale University, New Haven, CT, USA.
  • De la Cruz E; Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Jorge A; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic.
  • De Los Santos M; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic.
  • Leon P; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic.
  • Breban MI; Laboratorio de Referencia, Santo Domingo, Dominican Republic.
  • Billig K; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Yildirim I; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Pearson C; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Downing R; Yale Institute for Global Health, Yale University, New Haven, CT, USA.
  • Gagnon E; Section of Infectious Diseases and Global Health, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
  • Muyombwe A; Connecticut State Department of Public Health, Rocky Hill, CT, USA.
  • Razeq J; Connecticut State Department of Public Health, Rocky Hill, CT, USA.
  • Campbell M; Connecticut State Department of Public Health, Rocky Hill, CT, USA.
  • Ko AI; Connecticut State Department of Public Health, Rocky Hill, CT, USA.
  • Omer SB; Connecticut State Department of Public Health, Rocky Hill, CT, USA.
  • Grubaugh ND; Section of Infectious Diseases and Global Health, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
  • Vermund SH; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Iwasaki A; Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
Nat Med ; 28(3): 481-485, 2022 03.
Article em En | MEDLINE | ID: mdl-35051990
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article